FDA Inspection
Irwin Goldstein, MDIrwin Goldstein, MD – FDA Inspection, May 20, 2013
Record Details
This FDA Inspection record concerns Irwin Goldstein, MD, with an inspection on May 20, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Irwin Goldstein, MD
- Inspection Date
- May 20, 2013
- Product Type
- Drugs
View Company Profile
ID · 07718c3b-b342-479e-9572-ab01a8a8e98d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 832826
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Irwin Goldstein, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 22, 2013 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Irwin Goldstein, MD
- FDA Inspection 820922 - 2013-02-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.